These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 26033735)

  • 101. The synthesis and antibacterial activity study of ruthenium-based metallodrugs with a membrane-disruptive mechanism against
    Chen Y; Liu L; Wang X; Liao Z; Wang R; Xiong Y; Cheng J; Jiang G; Wang J; Liao X
    Dalton Trans; 2022 Oct; 51(39):14980-14992. PubMed ID: 36112764
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Nitazoxanide potentiates linezolid against linezolid-resistant Staphylococcus aureus in vitro and in vivo.
    Kaul G; Akhir A; Shukla M; Rawat KS; Sharma CP; Sangu KG; Rode HB; Goel A; Chopra S
    J Antimicrob Chemother; 2022 Aug; 77(9):2456-2460. PubMed ID: 35748613
    [TBL] [Abstract][Full Text] [Related]  

  • 103. FtsZ inhibitors as a new genera of antibacterial agents.
    Tripathy S; Sahu SK
    Bioorg Chem; 2019 Oct; 91():103169. PubMed ID: 31398602
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Synthesis and antibacterial activity of 3-benzylamide derivatives as FtsZ inhibitors.
    Hu Z; Zhang S; Zhou W; Ma X; Xiang G
    Bioorg Med Chem Lett; 2017 Apr; 27(8):1854-1858. PubMed ID: 28285910
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Biphenylthiazole antibiotics with an oxadiazole linker: An approach to improve physicochemical properties and oral bioavailability.
    Hagras M; Hegazy YA; Elkabbany AH; Mohammad H; Ghiaty A; Abdelghany TM; Seleem MN; Mayhoub AS
    Eur J Med Chem; 2018 Jan; 143():1448-1456. PubMed ID: 29126738
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Phenylthiazoles with nitrogenous side chain: An approach to overcome molecular obesity.
    Elsebaei MM; Abutaleb NS; Mahgoub AA; Li D; Hagras M; Mohammad H; Seleem MN; Mayhoub AS
    Eur J Med Chem; 2019 Nov; 182():111593. PubMed ID: 31446245
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Design, synthesis and biological evaluation of biphenyl-benzamides as potent FtsZ inhibitors.
    Deng J; Zhang T; Li B; Xu M; Wang Y
    Eur J Med Chem; 2022 Sep; 239():114553. PubMed ID: 35763867
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Relationships between structure, antibacterial activity, serum stability, pharmacokinetics and efficacy in 3-(heteroarylthio)cephems. Discovery of RWJ-333441 (MC-04,546).
    Glinka T; Huie K; Cho A; Ludwikow M; Blais J; Griffith D; Hecker S; Dudley M
    Bioorg Med Chem; 2003 Feb; 11(4):591-600. PubMed ID: 12538024
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Exposure of Methicillin-Resistant Staphylococcus aureus to Low Levels of the Antibacterial THAM-3ΦG Generates a Small Colony Drug-Resistant Phenotype.
    Weaver AJ; Peters TR; Tripet B; Van Vuren A; Rakesh ; Lee RE; Copié V; Teintze M
    Sci Rep; 2018 Jun; 8(1):9850. PubMed ID: 29959441
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Development of membrane-targeting TPP
    Li T; He X; Tao W; Zhang R; He Q; Gong H; Liu Y; Luo D; Zhang M; Zou C; Zhang SL; He Y
    Eur J Med Chem; 2024 Jan; 264():115973. PubMed ID: 38096652
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Development of Biphenylthiazoles Exhibiting Improved Pharmacokinetics and Potent Activity Against Intracellular
    Hagras M; Abutaleb NS; Elhosseiny NM; Abdelghany TM; Omara M; Elsebaei MM; Alhashimi M; Norvil AB; Gutay MI; Gowher H; Attia AS; Seleem MN; Mayhoub AS
    ACS Infect Dis; 2020 Nov; 6(11):2887-2900. PubMed ID: 32897045
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Enhancing targeted antibiotic therapy via pH responsive solid lipid nanoparticles from an acid cleavable lipid.
    Kalhapure RS; Sikwal DR; Rambharose S; Mocktar C; Singh S; Bester L; Oh JK; Renukuntla J; Govender T
    Nanomedicine; 2017 Aug; 13(6):2067-2077. PubMed ID: 28434930
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Discovery of a novel antibacterial protein CB6-C to target methicillin-resistant Staphylococcus aureus.
    Zhang H; Chen J; Liu Y; Xu Q; Inam M; He C; Jiang X; Jia Y; Ma H; Kong L
    Microb Cell Fact; 2022 Jan; 21(1):4. PubMed ID: 34983528
    [TBL] [Abstract][Full Text] [Related]  

  • 114. The study of 9,10-dihydroacridine derivatives as a new and effective molecular scaffold for antibacterial agent development.
    Chen CC; Zhang YQ; Zhong DX; Huang XH; Zhang YH; Jiang WH; Li M; Chen Q; Wong WL; Lu YJ
    Biochem Biophys Res Commun; 2021 Mar; 546():40-45. PubMed ID: 33561747
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Practical synthesis of PC190723, an inhibitor of the bacterial cell division protein FtsZ.
    Sorto NA; Olmstead MM; Shaw JT
    J Org Chem; 2010 Nov; 75(22):7946-9. PubMed ID: 21033691
    [TBL] [Abstract][Full Text] [Related]  

  • 116. FtsZ-Independent Mechanism of Division Inhibition by the Small Molecule PC190723 in Escherichia coli.
    Khare S; Hsin J; Sorto NA; Nepomuceno GM; Shaw JT; Shi H; Huang KC
    Adv Biosyst; 2019 Nov; 3(11):e1900021. PubMed ID: 32648693
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Second-Generation Phenylthiazole Antibiotics with Enhanced Pharmacokinetic Properties.
    Seleem MA; Disouky AM; Mohammad H; Abdelghany TM; Mancy AS; Bayoumi SA; Elshafeey A; El-Morsy A; Seleem MN; Mayhoub AS
    J Med Chem; 2016 May; 59(10):4900-12. PubMed ID: 27187739
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Novel pogostone analogous XW-12-loading nanoparticles display enhanced systematic activity against methicillin-resistant Staphylococcus aureus.
    Wang X; Wu F; Chen Y; Qin F; Bao J; Chen G
    J Microencapsul; 2018 Jan; 35(1):78-89. PubMed ID: 29308688
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Variations in the binding pocket of an inhibitor of the bacterial division protein FtsZ across genotypes and species.
    Miguel A; Hsin J; Liu T; Tang G; Altman RB; Huang KC
    PLoS Comput Biol; 2015 Mar; 11(3):e1004117. PubMed ID: 25811761
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Targeting fundamental pathways to disrupt Staphylococcus aureus survival: clinical implications of recent discoveries.
    Thomsen IP; Liu GY
    JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.